Systemic delivery of antagomirs during blood-brain barrier disruption is disease-modifying in experimental epilepsy.
Reschke CR, Silva LFA, Vangoor VR, Rosso M, David B, Cavanagh BL, Connolly NMC, Brennan GP, Sanz-Rodriguez A, Mooney C, Batool A, Greene C, Brennan M, Conroy RM, Rüber T, Prehn JHM, Campbell M, Pasterkamp RJ, Henshall DC.
Reschke CR, et al. Among authors: sanz rodriguez a.
Mol Ther. 2021 Jun 2;29(6):2041-2052. doi: 10.1016/j.ymthe.2021.02.021. Epub 2021 Feb 18.
Mol Ther. 2021.
PMID: 33609732
Free PMC article.